Medical Staff Pulse Newsletter

Dabigatran (Pradaxa) safety update

Pharmacy Focus

A safety update, reversal guidelines and a fact sheet regarding the anticoagulant dabigatran (Pradaxa®) were released recently.

» Read more

Meetings and events

Grand rounds

Click here to view upcoming Grand Rounds.

Upcoming CME conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - February 2012 (PDF)

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

New research institute looks at diabetes, obesity

One of the newest research initiatives at Cedars-Sinai Medical Center is the Diabetes and Obesity Research Institute, which was established in July 2011. Its goal is to examine the prediction, prevention, treatment and cure of diabetes, obesity and associated conditions.

The director of the institute, Richard Nathan Bergman, PhD, and associate director Marilyn Ader, PhD, as well as five additional faculty, postdoctoral fellows, students and allied personnel, moved to Cedars-Sinai from the University of Southern California.

In past years, Bergman was recognized for his group's achievements by receiving the prestigious Banting Medal from the American Diabetes Association and the TOPS Award from the Obesity Society. The group's contributions include the development of the Minimal Model Approach for assessment of metabolic status and the Disposition Index, the most powerful predictor of the onset of type 2 diabetes. Other areas of research include the mechanisms of insulin resistance, the consequences of abdominal obesity, the metabolic effects of psychotropic medications, and the use of mathematical modeling techniques to corroborate genetic loci that contribute to the risk of developing diabetes.

At Cedars-Sinai, new research initiatives have begun, including examination of the relationship between sleep patterns and diabetes, as well as mechanisms by which bariatric surgery reduces or even eliminates diabetes. The institute will play a role as a nexus for translational collaboration among the departments of Biomedical Sciences and Medicine, the S. Mark Taper Foundation Imaging Center, the Center for Hypertension at the Cedars-Sinai Heart Institute and the Department of Surgery as ongoing research relates to diabetes and obesity.

The new institute is designed to become a major force in leading-edge research to confront and mitigate one of the most problematic diseases in the U.S., with Cedars-Sinai well-positioned to play this leading role in the Western region.